566,000 Americans have died from AIDS since 1981. Last year total
federal spending on HIV/AIDS-related medical care, research, prevention,
and other activities was $23.3 billion; and
-- Remerging diseases, which were thought to be nearly eliminated in the
U.S., including measles, mumps, and tuberculosis (TB).
Worldwide, infectious diseases are the leading killer of children and adolescents, and are one of the leading causes of death for adults. According to the National Intelligence Estimate, "newly emerging and re-emerging infectious diseases ... will complicate U.S. and global security for the next 20 years. These diseases will endanger U.S. citizens at home and abroad, threaten U.S. armed forces deployed overseas, and exacerbate social and political instability in key countries and regions in which the U.S. has significant interests."
The Germs Go Global report examines major vulnerabilities in the
current U.S. strategy for combating infectious diseases, including:
-- Treatment: While the U.S. government has invested significantly in
treatments that could counter an intentional biological attack, new
drugs to treat emerging diseases and new antibiotics to address growing
antimicrobial resistance have received far less attention. The
development of new, improved therapies to treat drug resistant bacterial
infections, as well as influenza and other viruses, is essential.
-- Surveillance: Every state and local health department should be part of
a disease surveillance system that is interoperable among jurisdictions
and agencies to ensure rapid information sharing. Health information
technology (HIT) should be mobilized far more effectively to support
public health surveillance. And, the U.S. needs to be a leade
'/>"/>
| SOURCE Trust for America's Health Copyright©2008 PR Newswire. All rights reserved |